NCT02833233View on ClinicalTrials.gov

A Study of Pre-Operative Treatment With Cryoablation and Immune Therapy in Early Stage Breast Cancer

NACompletedINTERVENTIONAL

Enrollment

5

Participants

Timeline

Start Date

June 30, 2016

Primary Completion Date

June 7, 2024

Study Completion Date

June 7, 2024

Conditions

Breast Cancer

Interventions

PROCEDURE

Cryoablation

DRUG

Ipilimumab

DRUG

Nivolumab

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Memorial Sloan Kettering Cancer Center

OTHER